Kiniksa Pharmaceuticals International, plc 13F holders
265 funds reported a position in Kiniksa Pharmaceuticals International, plc in their 13F for the quarter ended 30 June 2026, together 46.9 million shares worth $2.99 billion. Against the quarter before, 63 opened a position, 86 added, 81 trimmed and 26 sold out; together they bought a net 1.5 million shares. The largest holders: FMR LLC, Rubric Capital Management LP and Baker Bros. Advisors LP.
What each fund did in KNSA against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in KNSA in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
3,241 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 57 reported a position in Kiniksa Pharmaceuticals International, plc: 13 opened one, 17 added, 15 trimmed and 2 sold out, a net 40,025 shares bought.
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 7 reported a position in Kiniksa Pharmaceuticals International, plc in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 7.0 million shares worth $445.8 million, 0.0% of its reported book. New this quarter: Renaissance Technologies. In the quarter, 5 funds added or opened a position and 2 trimmed or sold out; together they bought a net 30,558 shares, about $2.0 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 6,971,361 | $445.8 million | 0.0% | +147,661 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 659,493 | $42.2 million | 0.1% | +18,535 | added | 30 June 2026 | 13F |
| Geode Capital Management | 604,180 | $38.6 million | 0.0% | +559,860 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 561,480 | $35.9 million | 0.0% | +140,566 | added | 30 June 2026 | 13F |
| Millennium Management | 93,364 | $6.0 million | 0.0% | -471,056 | trimmed | 30 June 2026 | 13F |
| Renaissance Technologies | 68,077 | $4.4 million | 0.0% | +68,077 | new | 30 June 2026 | 13F |
| Citadel Advisors | 41,665 | $2.7 million | 0.0% | -433,085 | trimmed | 30 June 2026 | 13F |
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 6,971,361 | 14.85% | $445.8 million | 0.02% | +147,661 | 13F |
| Rubric Capital Management LP | 3,999,800 | 8.52% | $255.8 million | 2.35% | +249,800 | 13F |
| Baker Bros. Advisors LP | 2,834,643 | 6.04% | $181.3 million | 0.91% | +8,397 | 13F |
| BlackRock, Inc. | 2,739,615 | 5.84% | $175.2 million | 0.00% | +2,252,878 | 13F |
| Tang Capital Management LLC | 2,259,889 | 4.81% | $144.5 million | 6.60% | no change | 13F |
| Vanguard Portfolio Management LLC | 1,911,335 | 4.07% | $122.2 million | 0.01% | +145,067 | 13F |
| Vanguard Capital Management LLC | 1,360,840 | 2.90% | $87.0 million | 0.00% | +27,747 | 13F |
| Morgan Stanley | 1,011,143 | 2.15% | $64.7 million | 0.00% | +13,357 | 13F |
| Arrowstreet Capital, Limited Partnership | 957,514 | 2.04% | $61.2 million | 0.03% | +64,848 | 13F |
| Spruce Street Capital LP | 918,070 | 1.96% | $58.7 million | 11.52% | +157,007 | 13F |
| Dimensional Fund Advisors LP | 874,786 | 1.86% | $55.9 million | 0.01% | +62,864 | 13F |
| Invesco Ltd. | 772,806 | 1.65% | $49.4 million | 0.00% | +745,150 | 13F |
| Driehaus Capital Management LLC | 718,199 | 1.53% | $45.9 million | 0.27% | +106,801 | 13F |
| State Street Corp. | 704,194 | 1.50% | $45.0 million | 0.00% | +627,561 | 13F |
| Acadian Asset Management LLC | 679,083 | 1.45% | $43.4 million | 0.05% | -657,230 | 13F |
| Point72 Asset Management, L.P. | 659,493 | 1.41% | $42.2 million | 0.07% | +18,535 | 13F |
| Rice Hall James & Associates, LLC | 624,928 | 1.33% | $40.0 million | 1.95% | +16,512 | 13F |
| Pictet Asset Management Holding SA | 608,650 | 1.30% | $38.9 million | 0.04% | -14,638 | 13F |
| Geode Capital Management, LLC | 604,180 | 1.29% | $38.6 million | 0.00% | +559,860 | 13F |
| Jupiter Topco LLC | 586,177 | 1.25% | $37.5 million | 0.01% | first 13F | 13F |
| Connor, Clark & Lunn Investment Management Ltd. | 572,598 | 1.22% | $36.6 million | 0.07% | -77,031 | 13F |
| D. E. Shaw & Co., Inc. | 569,756 | 1.21% | $36.4 million | 0.02% | -389,501 | 13F |
| Two Sigma Investments, LP | 561,480 | 1.20% | $35.9 million | 0.03% | +140,566 | 13F |
| Victory Capital Management Inc. | 504,853 | 1.08% | $32.3 million | 0.02% | -1,668 | 13F |
| SG Americas Securities, LLC | 504,001 | 1.07% | $32.2 million | 0.02% | -136,178 | 13F |
| BNP Paribas Financial Markets | 437,192 | 0.93% | $28.0 million | 0.01% | -210,539 | 13F |
| Massachusetts Financial Services Co. | 431,324 | 0.92% | $27.6 million | 0.01% | -6,678 | 13F |
| Orbimed Advisors LLC | 420,600 | 0.90% | $26.9 million | 0.51% | +240,001 | 13F |
| AllianceBernstein L.P. | 556,151 | 1.18% | $26.8 million | 0.01% | -42,737 | 13F |
| Bank of America Corp. | 413,411 | 0.88% | $26.4 million | 0.00% | -322,529 | 13F |
| Oberweis Asset Management Inc. | 413,034 | 0.88% | $26.4 million | 0.55% | +94,400 | 13F |
| Aberdeen Group plc | 403,485 | 0.86% | $25.8 million | 0.04% | +29,851 | 13F |
| Fisher Asset Management, LLC | 398,266 | 0.85% | $25.5 million | 0.01% | -30,706 | 13F |
| Deutsche Bank AG | 387,606 | 0.83% | $24.8 million | 0.01% | -136,085 | 13F |
| AQR Capital Management LLC | 375,039 | 0.80% | $24.0 million | 0.01% | -3,658 | 13F |
| Penn Capital Management Company, LLC | 368,114 | 0.78% | $23.6 million | 1.50% | +66,121 | 13F |
| Northern Trust Corp. | 315,246 | 0.67% | $20.2 million | 0.00% | +278,322 | 13F |
| Balyasny Asset Management L.P. | 309,682 | 0.66% | $19.8 million | 0.04% | -190,110 | 13F |
| Qube Research & Technologies Ltd | 304,080 | 0.65% | $19.4 million | 0.02% | -382,773 | 13F |
| New York State Common Retirement Fund | 272,579 | 0.58% | $17.4 million | 0.02% | +62,962 | 13F |
| Nomura Holdings Inc. | 270,724 | 0.58% | $17.3 million | 0.07% | -72,215 | 13F |
| Soleus Capital Management, L.P. | 246,353 | 0.52% | $15.8 million | 0.54% | -275,000 | 13F |
| Essex Investment Management Co. LLC | 241,382 | 0.51% | $15.4 million | 2.02% | -7,896 | 13F |
| Bank of New York Mellon Corp | 232,531 | 0.50% | $14.9 million | 0.00% | +215,143 | 13F |
| ArrowMark Colorado Holdings LLC | 215,546 | 0.46% | $13.8 million | 0.57% | -101,410 | 13F |
| Stempoint Capital LP | 209,234 | 0.45% | $13.4 million | 2.31% | new | 13F |
| Goldman Sachs Group Inc. | 191,364 | 0.41% | $12.2 million | 0.00% | +16,463 | 13F |
| Sei Investments Co. | 188,565 | 0.40% | $12.1 million | 0.01% | -95,440 | 13F |
| Braidwell LP | 183,822 | 0.39% | $11.8 million | 0.45% | -88,700 | 13F |
| Castleark Management LLC | 174,032 | 0.37% | $11.1 million | 0.30% | -7,480 | 13F |
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on KNSA
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 14,100 | $901,695 | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 5,700 | $364,515 | 30 June 2026 | 13F |
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 29 July 2026 | 13G | BlackRock, Inc. and 1 other | 2.5 million | 5.5% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 May 2026 | 13D/A | Baker Bros. Advisors LP and 4 others | 3.3 million | 7.0% | 21 May 2026 | Item 4 of Schedule 13D is supplemented and amended, as the case may be, as follows: On May 21, 2026, Kiniksa Pharmaceuticals International, plc (the "Issuer") and the Adviser on behalf of the Funds entered into a Deed of Waiver (the "Deed") | EDGAR |
| 6 May 2026 | 13G/A | FMR LLC and 3 others | 6.8 million | 14.8% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 6 March 2026 | 13G | FMR LLC and 3 others | 4.9 million | 10.6% | 27 February 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 13 February 2026 | 13G/A | Rubric Capital Management LP and 3 others | 3.3 million | 7.4% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 31 October 2025 | 13G/A | The Vanguard Group and 1 other | 3.1 million | 7.0% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 22 September 2026 | 2 | $78.13 | SEC |
| 17 September 2026 | 9,617 | $77.62 | SEC |
| 9 September 2026 | 1 | $77.09 | SEC |
| 8 September 2026 | 1 | $77.91 | SEC |
| 4 September 2026 | 1 | $80.47 | SEC |
| 3 September 2026 | 178 | $79.89 | SEC |
| 28 August 2026 | 2,050 | $79.80 | SEC |
| 27 August 2026 | 6 | $78.68 | SEC |
| 26 August 2026 | 6 | $80.20 | SEC |
| 25 August 2026 | 5 | $79.38 | SEC |
| 20 August 2026 | 9 | $80.80 | SEC |
| 18 August 2026 | 89 | $79.18 | SEC |